The plusses and minuses of bone marrow-derived mesenchymal stem cells in the treatment of liver cirrhosis

被引:0
作者
Zhao, Yipu [1 ,2 ]
Huang, Shuai [1 ,2 ]
Zhu, Rongtao [1 ,2 ]
Sun, Yuling [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Sch Med, Inst Hepatobiliary & Pancreat Dis, Zhengzhou 450052, Henan, Peoples R China
关键词
Bone marrow; mesenchymal stem cells; liver cirrhosis; stem cell therapy; HEPATOCYTE GROWTH-FACTOR; HEPATIC STELLATE CELLS; UMBILICAL-CORD BLOOD; IN-VITRO; STROMAL CELLS; SHORT-TERM; DIFFERENTIATION; TRANSPLANTATION; FIBROSIS; INFUSION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Liver transplantation is the most effective treatment for advanced liver disease, but its application is restricted. Cell therapy provides a fresh approach for treating liver cirrhosis. The immunological superiority and stem cell characteristics of mesenchymal stem cells (MSCs) from bone marrow, umbilical cord, adipose tissue, or dental tissues might allow them to perform well as alternative cell therapy treatments. Many previous animal experiments and clinical studies of liver disease have been reported and have demonstrated the efficacy and safety of MSCs therapy; no serious side effects or complications were noted, but not all trials have shown efficacy. Potential mechanisms of action, for example, secreting cytokines and growth factors, promoting liver regeneration, inhibiting inflammation in the liver, facilitating the degradation of excessive extracellular matrix (ECM) and differentiating into multi-lineage cells, could account for how MSCs therapy helps improve liver function. However, exploring the mechanism of action still requires further study, and a multitude of problems still await solutions in clinical practice. The use of MSCs in treating liver disease shows broad potential as well as undoubted challenges. In this paper, we will focus on the current possible mechanisms by which bone marrow mesenchymal stem cells (BM-MSCs) improve liver function, show the relationship between the application of MSCs and the occurrence of liver tumors and hepatic fibrosis, and present recent controversies and prospects for the treatment of liver cirrhosis.
引用
收藏
页码:8801 / 8811
页数:11
相关论文
共 86 条
[51]   Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing [J].
Neuss, S ;
Becher, E ;
Wöltje, M ;
Tietze, L ;
Jahnen-Dechent, W .
STEM CELLS, 2004, 22 (03) :405-414
[52]   A novel role of hepatocyte growth regulator through suppressing factor as an immune dendritic cell function [J].
Okunishi, K ;
Dohi, M ;
Nakagome, K ;
Tanaka, R ;
Mizuno, S ;
Matsumoto, K ;
Miyazaki, J ;
Nakamura, T ;
Yamamoto, K .
JOURNAL OF IMMUNOLOGY, 2005, 175 (07) :4745-4753
[53]   Hepatic differentiation potential of commercially available human mesenchymal stem cells [J].
Ong, Shin-Yeu ;
Dai, Hui ;
Leong, Kam W. .
TISSUE ENGINEERING, 2006, 12 (12) :3477-3485
[54]   Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells [J].
Pan, Qiuwei ;
Fouraschen, Suomi M. G. ;
de Ruiter, Petra E. ;
Dinjens, Winand N. M. ;
Kwekkeboom, Jaap ;
Tilanus, Hugo W. ;
van der Laan, Luc J. W. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 239 (01) :105-115
[55]   Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells [J].
Parekkadan, Biju ;
van Poll, Daan ;
Megeed, Zaki ;
Kobayashi, Naoya ;
Tilles, Arno W. ;
Berthiaume, Francois ;
Yarmush, Martin L. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 363 (02) :247-252
[56]   Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Liver Failure Patients Caused by Hepatitis B: Short-Term and Long-Term Outcomes [J].
Peng, Liang ;
Xie, Dong-ying ;
Lin, Bing-Liang ;
Liu, Jing ;
Zhu, Hai-peng ;
Xie, Chan ;
Zheng, Yu-bao ;
Gao, Zhi-liang .
HEPATOLOGY, 2011, 54 (03) :820-828
[57]   Relearning the Lessons of Genomic Stability of Human Cells During Expansion in Culture: Implications for Clinical Research [J].
Prockop, Darwin J. ;
Keating, Armand .
STEM CELLS, 2012, 30 (06) :1051-1052
[58]   Canine mesenchymal stem cells show antioxidant properties against thioacetamide-induced liver injury in vitro and in vivo [J].
Quintanilha, Luiz Fernando ;
Takami, Taro ;
Hirose, Yoshikazu ;
Fujisawa, Koichi ;
Murata, Yasuhiko ;
Yamamoto, Naoki ;
dos Santos Goldenberg, Regina Coeli ;
Terai, Shuji ;
Sakaida, Isao .
HEPATOLOGY RESEARCH, 2014, 44 (10) :E206-E217
[59]   The bone marrow functionally contributes to liver fibrosis [J].
Russo, Francesco P. ;
Alison, Malcolm R. ;
Bigger, Brian W. ;
Amofah, Eunice ;
Florou, Aikaterini ;
Amin, Farhana ;
Bou-Gharios, George ;
Jeffery, Rosemary ;
Iredale, John P. ;
Forbes, Stuart J. .
GASTROENTEROLOGY, 2006, 130 (06) :1807-1821
[60]   Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice [J].
Sakaida, I ;
Terai, S ;
Yamamoto, N ;
Aoyama, K ;
Ishikawa, T ;
Nishina, H ;
Okita, K .
HEPATOLOGY, 2004, 40 (06) :1304-1311